🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Marina Bacac

Roche (Switzerland)

ORCID: 0000-0003-0581-9579

Also affiliated with Zurich Insurance Group (Switzerland)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Explainable machine learning for profiling the immunological synapse and functional characterization of therapeutic antibodies”.

Explainable machine learning for profiling the immunological synapse and functional characterization of therapeutic antibodies

Nature Communications(2023)10.1038/s41467-023-43429-2

N/A

0.689DataRank · unranked

21 citations

Katharina Essig, Sylvia Herter, Marina Bacac, Fabian Joachim Theis, Elke Glasmacher +4 more

Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor Immunity

Frontiers in Immunology(2021)10.3389/fimmu.2021.726492

N/A

0.590DataRank · unranked

50 citations

Ramya Sivakumar, Leo Kunz, Brandy Olin, Elena Menietti, Dario Speziale +6 more

scifAI: Explainable machine learning for profiling the immunological synapse and functional characterization of therapeutic antibodies

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.24.513494

N/A

0.104DataRank · unranked

1 citations

Katharina Essig, Nikolaos‐Kosmas Chlis, Sylvia Herter, Marina Bacac, Fabian Joachim Theis +4 more

PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells

Nature(2022)10.1038/s41586-022-05192-0

N/A

0DataRank · unranked

275 citations

Valeria Nicolini, Masao Hashimoto, Maria Karagianni, Petra Schwalie, Laura Lauener +30 more

A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-22-0201

N/A

0DataRank · unranked

33 citations

Inja Waldhauer, Ester Planas‐Rigol, Ester Bonfill‐Teixidor, Alexandra Arias, Valeria Nicolini +30 more

Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial

Blood(2023)10.1182/blood.2023020554

N/A

0DataRank · unranked

21 citations

Victoria Wang, Tait D. Shanafelt, Connie Lesnick, Nikolaos Ioannou, Giulia De Rossi +7 more

scifAI: Explainable machine learning for profiling the immunological synapse and functional characterization of therapeutic antibodies

Research Square(2022)10.21203/rs.3.rs-2190942/v1

N/A

0DataRank · unranked

0 citations

Katharina Essig, Nikolaos Kosmas Chlis, Sylvia Herter, Marina Bacac, Fabian Joachim Theis +4 more

Resolving the structural basis of therapeutic antibody function in cancer immunotherapy with RESI

Nature Communications(2025)10.1038/s41467-025-61893-w

N/A

0DataRank · unranked

4 citations

Luciano A. Masullo, S. Reinhardt, Jisoo Kwon, Maite Llop, Ondřej Skořepa +5 more

The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment

Cancer Research(2020)10.1158/0008-5472.can-19-3269

N/A

0DataRank · unranked

54 citations

Tove Olafsen, Alessandro Mascioni, Ziyue Karen Jiang, Charles Zamilpa, Fang Jia +24 more

Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated with Anti-Tumor Immunity

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.17.448881

N/A

0DataRank · unranked

5 citations

Ramya Sivakumar, Leo Kunz, BE Olin Pope, Elena Menietti, Dario Speziale +6 more